Decline isn't inevitable. It's a System out of Sync.

At its core, metabolic disease happens when the body forgets how to turn food into energy. Fuel becomes storage. Insulin stops helping. Energy gets trapped instead of used.

But it’s not just about weight. It’s about a system that’s out of balance.

We’ve mistaken decline for aging. For decades, medicine treated each symptom—blood sugar, cholesterol, weight gain, blood pressure—as a separate fight. This approach has only led to more drugs, higher costs, and a disease that keeps spreading.

But the good news is, it doesn’t have to be this way. The answer isn’t another refill. It’s reversal. When you restore how your cells use energy, you stop the spiral.

Don’t just manage disease, reverse it.
Read the full Report

The human impact of metabolic disease

25%
of Adults take 5+ prescription drugs a day
33%
of adults report daily fatigue
25%
of American adults struggle
with chronic joint pain
14 yrs
Cut from life expectancy

Myths vs Reality

Myth
Reality
Weight loss is just “eat less and exercise more.”
Metabolism, hormones, sleep, stress, and insulin play a major role in weight gain. In the long run, you can't willpower your way past biology.
Myth
Reality
Carbs are bad.
One-size-fits-all nutrition doesn’t work. Metabolic health, insulin response, and food quality matter more than rigid rules.
Myth
Reality
You should eat less as you age.
Most people (including women) need more protein, strength training, and nutrient density, not restrictive eating patterns.

How will you take control?

take the quiz

Every number in this report is backed by real results drawn from Virta’s extensive body of clinical research and real-world outcomes.

Our data come from peer-reviewed clinical trials conducted over varying study periods, Virta’s longitudinal program datasets spanning the past decade, and de-identified, aggregated real-world results from our active book of business and from a data clearinghouse.

Weight-loss outcomes represent average results among members who began Virta with a BMI ≥ 30. A1C reduction outcomes reflect high-risk type 2 diabetes members who started with a baseline A1C ≥ 9%, evaluated at one year unless otherwise noted.

Each analysis is independently reviewed and validated by Virta’s data science and research teams to ensure methodological accuracy and consistency with findings. Together, these data tell a clear, consistent story: reversal works, at scale.